Stay updated on Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    A notice about NIH website terminology appears above the ClinicalTrials.gov page, which still displays a 403 error instead of the study record. The site revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T21:57:02.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T21:48:02.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previously visible study record content and navigation. This indicates an access restriction is in effect for this study page.
    Difference
    18%
    Check dated 2026-09-22T22:56:31.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page's revision tag has been updated to v3.7.0, replacing the previous v3.6.6. This signals that the study record has been refreshed to a newer version.
    Difference
    0.1%
    Check dated 2026-09-15T21:35:08.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    A new revision tag Revision: v3.6.6 has been added. Several footer-related items were removed: Bladder cancer, related topics:, MedlinePlus Genetics, and Revision: v3.6.5.
    Difference
    0.2%
    Check dated 2026-09-08T17:48:56.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    Bladder cancer and a MedlinePlus Genetics entry have been added to the related topics section, linking the study to condition-specific information and genetics resources. This enhances navigational context for users exploring the trial.
    Difference
    0.2%
    Check dated 2026-08-25T21:58:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.